LBank Weekly Listing Report, 3rd January 2023
Internet City, Dubai–(Newsfile Corp. – January 4, 2023) – As a world class digital asset…
Internet City, Dubai–(Newsfile Corp. – January 4, 2023) – As a world class digital asset…
Bucharest, Romania–(Newsfile Corp. – January 4, 2023) – OnLaptop, a recognized leader in laptop repairs,…
TOKYO, Jan 5, 2023 – (JCN Newswire) – Mitsubishi Corporation and ENEOS Corporation are pleased…
Strategic partnership: Joint development of perception solutions and full-stack systems for advanced driver assistance and…
Intel (INTC), CBOE Global Markets (CBOE), Nu Holdings (NU), and Applied Blockchain (APLD) enter the…
IAC will run on the famed Monza F1 Circuit to push new boundaries in 2023…
Hong Kong, PRC, Jan 5, 2023 – (ACN Newswire) – China South City Holdings Limited…
NASHVILLE, Tenn.–(BUSINESS WIRE)–Montecito Medical, a leading acquirer of medical office properties nationwide, has completed the…
ROCKVILLE, MD, Jan. 04, 2023 (GLOBE NEWSWIRE) — MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical…
Carlsbad, CA, Jan. 04, 2023 (GLOBE NEWSWIRE) — Palisade Bio, Inc. (Nasdaq: PALI), a clinical stage biopharmaceutical…
• Maximum Potential Dilution of Approximately 23.04%, Based on Share Capital of Cellectis as of…
SOUTH SAN FRANCISCO, Calif., Jan. 04, 2023 (GLOBE NEWSWIRE) — Surrozen, Inc. (“Surrozen” or the…
ROCKVILLE, Md., Jan. 04, 2023 (GLOBE NEWSWIRE) — OpGen, Inc. (Nasdaq: OPGN, “OpGen” or “the…
ROCKVILLE, MD, Jan. 04, 2023 (GLOBE NEWSWIRE) — MacroGenics, Inc. (NASDAQ: MGNX), a biopharmaceutical company focused…
Veteran executive brings more than 30 years of biopharmaceutical public relations and public affairs experience FLORHAM…
SOUTH SAN FRANCISCO, Calif., Jan. 04, 2023 (GLOBE NEWSWIRE) — DICE Therapeutics, Inc. (Nasdaq: DICE),…
SAN DIEGO, Jan. 04, 2023 (GLOBE NEWSWIRE) — Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage…
SANTA CLARA, Calif., Jan. 04, 2023 (GLOBE NEWSWIRE) — Shockwave Medical, Inc. (Nasdaq: SWAV), a…
BOSTON, Jan. 04, 2023 (GLOBE NEWSWIRE) — HilleVax, Inc. (Nasdaq: HLVX), a clinical-stage biopharmaceutical company…